Aversion therapy has what kind of evidence regarding efficacy?

Aversion therapy has what kind of evidence regarding efficacy?

• A. Coupling drug/alcohol use with an unpleasant experience; controlled trials have had mixed results
• B. Widely successful across all substances
• C. Ineffective and never used
• D. Always harmful

Answer: (A)

Aversion therapy is based on classical conditioning: it pairs using a substance with an unpleasant reaction so that future use becomes associated with discomfort. In practice, that means delivering an aversive stimulus—such as a nausea-inducing agent or another unpleasant cue—when the person consumes alcohol (or another substance). When we examine controlled trials, the results are mixed rather than uniformly positive. Some people show short-term reductions in use, but these gains often don’t endure after treatment ends, and relapse is common. The effectiveness seems to depend on factors like motivation, the intensity and relevance of the unpleasant stimulus, and the context in which treatment occurs, so gains aren’t reliable across all individuals and all substances. While aversion therapy isn’t inherently or universally harmful, it carries ethical concerns and safety risks and is less commonly used today because the evidence for durable, broad-based success is inconsistent.

Aversion therapy is based on classical conditioning: it pairs using a substance with an unpleasant reaction so that future use becomes associated with discomfort. In practice, that means delivering an aversive stimulus—such as a nausea-inducing agent or another unpleasant cue—when the person consumes alcohol (or another substance). When we examine controlled trials, the results are mixed rather than uniformly positive. Some people show short-term reductions in use, but these gains often don’t endure after treatment ends, and relapse is common. The effectiveness seems to depend on factors like motivation, the intensity and relevance of the unpleasant stimulus, and the context in which treatment occurs, so gains aren’t reliable across all individuals and all substances. While aversion therapy isn’t inherently or universally harmful, it carries ethical concerns and safety risks and is less commonly used today because the evidence for durable, broad-based success is inconsistent.